New Findings in eNOS gene and Thalidomide Embryopathy Suggest pre-transcriptional effect variants as susceptibility factors

Antiangiogenic properties of thalidomide have created an interest in the use of the drug in treatment of cancer. However, thalidomide is responsible for thalidomide embryopathy (TE). A lack of knowledge regarding the mechanisms of thalidomide teratogenesis acts as a barrier in the aim to synthesize...

Descripción completa

Detalles Bibliográficos
Autores principales: Kowalski, Thayne Woycinck, Fraga, Lucas Rosa, Tovo-Rodrigues, Luciana, Sanseverino, Maria Teresa Vieira, Hutz, Mara Helena, Schuler-Faccini, Lavínia, Vianna, Fernanda Sales Luiz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4804217/
https://www.ncbi.nlm.nih.gov/pubmed/27004986
http://dx.doi.org/10.1038/srep23404

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4804217/
https://www.ncbi.nlm.nih.gov/pubmed/27004986
http://dx.doi.org/10.1038/srep23404

Ejemplares similares